Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Putative neuropeptide Y antagonist failed to decrease overeating in obese Zucker rats

B Beck1, A Stricker-Krongrad, N Musse

  • 1INSERM U.308, Mécanismes de Régulation du Comportement Alimentaire, Nancy, France.

Neuroscience Letters
|November 7, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depressive traits are associated with a reduced effect of choice on intentional binding.

Consciousness and cognition·2022
Same author

[Update on toxoplasmosis in poultry farming].

Schweizer Archiv fur Tierheilkunde·2022
Same author

Biomimetic reconstruction of the hematopoietic stem cell niche for in vitro amplification of human hematopoietic stem cells.

PloS one·2020
Same author

Associations between physical activity and bone structure in older adults: does the use of self-reported versus objective assessments of physical activity influence the relationship?

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

Post-discharge oral antimicrobial use among hospitalized patients across an integrated national healthcare network.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Why urban teens turn to guns: urban teens' own words on gun violence.

Public health·2019
Same journal

Dynorphinergic neuroadaptations in the islands of Calleja: implications for alcohol use disorder.

Neuroscience letters·2026
Same journal

Differential vulnerability of cochlear nuclei to Lmx1 deficiency: abnormal patterning and implications for auditory circuitry.

Neuroscience letters·2026
Same journal

Role of nNOS/sGC pathway in the insular cortex in control of cardiovascular, autonomic and corticosterone responses to restraint stress in rats.

Neuroscience letters·2026
Same journal

Jak1 inhibition reduces acute allodynia induced by specific upstream cytokines in rats: implications for the onset of Jak1 pain modulation.

Neuroscience letters·2026
Same journal

Glucocorticoids-induced depressive-like behaviors in mice: oral ingestion of corticosterone or hydrocortisone - A comparative study.

Neuroscience letters·2026
Same journal

Data-driven clustering of prefrontal activation identifies functional phenotypes under prioritized dual-task walking conditions in Parkinson's disease.

Neuroscience letters·2026
See all related articles

The NPY antagonist PYX-2 did not reduce food intake in obese Zucker rats. This suggests PYX-2 may not effectively target the Y1 receptors responsible for regulating feeding behavior in obesity.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Obesity Research

Background:

  • Obese Zucker rats exhibit hyperphagia, potentially due to neuropeptide dysregulation.
  • Neuropeptide Y (NPY) stimulates food intake and is implicated in the hyperphagia observed in obese rats.

Purpose of the Study:

  • To evaluate the efficacy of the NPY antagonist PYX-2 in reducing food intake in obese hyperphagic Zucker rats.
  • To determine if PYX-2 could be a potential therapeutic agent for managing excessive food intake.

Main Methods:

  • Ten adult male Zucker rats received intracerebroventricular injections of four doses of PYX-2 (50-1000 pmol) or artificial cerebrospinal fluid (vehicle).
  • Food intake was measured at multiple time points (0.5, 1, 2, 3, 6, and 23 hours) post-injection.
  • Results were compared to spontaneous food intake and intake following vehicle administration.

Related Experiment Videos

Main Results:

  • PYX-2 administration did not significantly alter food intake at any tested dose or time point.
  • At 1 hour post-injection, food intake was 4.3 ± 0.5 g for 1000 pmol PYX-2 versus 4.6 ± 0.8 g for vehicle (N.S.).
  • Over 23 hours, food intake was 27.0 ± 1.9 g for 1000 pmol PYX-2 versus 26.6 ± 2.9 g for vehicle (N.S.).

Conclusions:

  • The NPY antagonist PYX-2 failed to inhibit food intake in obese Zucker rats.
  • The lack of efficacy may stem from PYX-2's structure, potentially hindering recognition by Y1-type NPY receptors involved in feeding regulation.